Sood Anil K, Coffin Jeremy E, Schneider Galen B, Fletcher Mavis S, DeYoung Barry R, Gruman Lynn M, Gershenson David M, Schaller Michael D, Hendrix Mary J C
Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
Am J Pathol. 2004 Oct;165(4):1087-95. doi: 10.1016/S0002-9440(10)63370-6.
Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase that is activated by integrin clustering. There are limited data regarding the functional role of FAK in ovarian cancer migration and invasion. In the current study, FAK expression was evaluated in ovarian cell lines (nontransformed and cancer), 12 benign ovarian samples, and in 79 invasive epithelial ovarian cancers. All three ovarian cancer cell lines overexpressed FAK compared to the nontransformed cells. The dominant-negative construct called FAK-related nonkinase (FRNK) was introduced into two ovarian cancer cell lines (SKOV3 and 222). FRNK promoted FAK dephosphorylation without changing total FAK levels in these cell lines. Furthermore, FRNK decreased the in vitro invasive ability of ovarian cancer cells by 56 to 85% and decreased migration by 52 to 68%. FRNK-transfected cells also displayed poor cell spreading. Immunohistochemical analysis revealed that the surface epithelium from all benign ovarian samples had weak FAK expression. In contrast, 68% of invasive ovarian cancers overexpressed FAK. FAK overexpression was significantly associated with high tumor stage, high tumor grade, positive lymph nodes and presence of distant metastasis (all P values <0.05). FAK overexpression was also associated with shorter overall survival (P = 0.008). Multivariate analysis revealed that FAK overexpression and residual disease >1 cm were independent predictors of poor survival. These data indicate that FAK is overexpressed in most invasive ovarian cancers and plays a functionally significant role in ovarian cancer migration and invasion. Thus, FAK may be an important therapeutic target in ovarian carcinoma.
粘着斑激酶(FAK)是一种非受体酪氨酸激酶,可被整合素聚集激活。关于FAK在卵巢癌迁移和侵袭中的功能作用的数据有限。在本研究中,对卵巢细胞系(未转化和癌细胞系)、12例良性卵巢样本以及79例侵袭性上皮性卵巢癌中的FAK表达进行了评估。与未转化细胞相比,所有三种卵巢癌细胞系均过度表达FAK。将称为FAK相关非激酶(FRNK)的显性负性构建体导入两种卵巢癌细胞系(SKOV3和222)。FRNK促进了这些细胞系中FAK的去磷酸化,而不改变总FAK水平。此外,FRNK使卵巢癌细胞的体外侵袭能力降低了56%至85%,迁移能力降低了52%至68%。转染FRNK的细胞也表现出较差的细胞铺展。免疫组织化学分析显示,所有良性卵巢样本的表面上皮FAK表达较弱。相比之下,68%的侵袭性卵巢癌过度表达FAK。FAK过度表达与高肿瘤分期、高肿瘤分级、阳性淋巴结和远处转移的存在显著相关(所有P值<0.05)。FAK过度表达还与较短的总生存期相关(P = 0.008)。多变量分析显示,FAK过度表达和残留疾病>1 cm是生存不良的独立预测因素。这些数据表明,FAK在大多数侵袭性卵巢癌中过度表达,并在卵巢癌迁移和侵袭中发挥功能上的重要作用。因此,FAK可能是卵巢癌的一个重要治疗靶点。